tetano
Editor, Senior Moderator
Intern Med
. 2022 Feb 1.
doi: 10.2169/internalmedicine.9171-21. Online ahead of print.
Temporal Changes in Brain Perfusion in a Patient with Myoclonus and Ataxia Syndrome Associated with COVID-19
Kenta Osawa[SUP] 1 [/SUP], Atsuhiko Sugiyama[SUP] 1 [/SUP], Akiyuki Uzawa[SUP] 1 [/SUP], Shigeki Hirano[SUP] 1 [/SUP], Tatsuya Yamamoto[SUP] 1 2 [/SUP], Masahiko Nezu[SUP] 3 [/SUP], Nobuyuki Araki[SUP] 1 [/SUP], Hiroki Kano[SUP] 1 [/SUP], Satoshi Kuwabara[SUP] 1 [/SUP]
Affiliations
Abstract
Myoclonus and ataxia, with or without opsoclonus, have recently been recognized as a central nervous system syndrome associated with coronavirus disease-2019 (COVID-19). A 52-year-old Japanese man developed myoclonus and ataxia 16 days after the onset of COVID-19. Brain single-photon emission computed tomography (SPECT) revealed hyperperfusion in the cerebellum and hypoperfusion in the cerebral cortices with frontal predominance during the acute stage, which improved over two months. This study indicates that brain perfusion SPECT can be effective in detecting functional alterations in COVID-19-related myoclonus and ataxia.
Keywords: COVID-19; ataxia; brain perfusion; myoclonus.
. 2022 Feb 1.
doi: 10.2169/internalmedicine.9171-21. Online ahead of print.
Temporal Changes in Brain Perfusion in a Patient with Myoclonus and Ataxia Syndrome Associated with COVID-19
Kenta Osawa[SUP] 1 [/SUP], Atsuhiko Sugiyama[SUP] 1 [/SUP], Akiyuki Uzawa[SUP] 1 [/SUP], Shigeki Hirano[SUP] 1 [/SUP], Tatsuya Yamamoto[SUP] 1 2 [/SUP], Masahiko Nezu[SUP] 3 [/SUP], Nobuyuki Araki[SUP] 1 [/SUP], Hiroki Kano[SUP] 1 [/SUP], Satoshi Kuwabara[SUP] 1 [/SUP]
Affiliations
- PMID: 35110499
- DOI: 10.2169/internalmedicine.9171-21
Abstract
Myoclonus and ataxia, with or without opsoclonus, have recently been recognized as a central nervous system syndrome associated with coronavirus disease-2019 (COVID-19). A 52-year-old Japanese man developed myoclonus and ataxia 16 days after the onset of COVID-19. Brain single-photon emission computed tomography (SPECT) revealed hyperperfusion in the cerebellum and hypoperfusion in the cerebral cortices with frontal predominance during the acute stage, which improved over two months. This study indicates that brain perfusion SPECT can be effective in detecting functional alterations in COVID-19-related myoclonus and ataxia.
Keywords: COVID-19; ataxia; brain perfusion; myoclonus.